Semaglutide for Prostate Cancer

NM
Overseen ByNibu Mathew
Age: 18+
Sex: Male
Trial Phase: Phase < 1
Sponsor: Banner Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

In this exploratory, single-arm, nonrandomized trial, the impact of the preoperative utilization of the glucagon-like peptide-1 (GLP-1) receptor agonist (RA) semaglutide prior to radical prostatectomy in participants with intermediate risk prostate cancer will be investigated. Semaglutide will be administered according to the FDA-approved label for chronic weight management and participants will be dosed with a weekly subcutaneous injection. The primary aim of this trial is to explore the tumor biological activity of semaglutide in these participants. The trial will also evaluate the safety and tolerability of this preoperative treatment, along with the impact on physiologic/metabolic parameters.

Who Is on the Research Team?

IB

Issac Bowman

Principal Investigator

Banner Health

Are You a Good Fit for This Trial?

This trial is for people with intermediate-risk prostate cancer who are scheduled to have their prostate removed by surgery. Participants should be able to safely receive semaglutide and follow the study procedures.

Inclusion Criteria

Body mass index (BMI) >35 kg/m²
I am a man who is 18 years old or older.
My prostate cancer is intermediate-risk and confirmed by biopsy.
See 2 more

Exclusion Criteria

I have a stomach or swallowing problem that makes it hard to eat normally.
I am currently using or have recently used GLP-1 receptor agonist medication.
My prostate cancer is not classified as intermediate risk.
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • Semaglutide

Trial Overview

The study tests weekly injections of semaglutide, a medication usually used for weight management, before prostate removal surgery. It aims to see how the drug affects the tumor and overall health in these patients.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Semaglutide Preoperative TreatmentExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Banner Health

Lead Sponsor

Trials
26
Recruited
1,006,000+